Insulet Initiates EVOLVE Pivotal Study for Automated Insulin Delivery System

Clinical Trials, Studies & Reports May 4, 2026

Insulet Corporation has launched the EVOLVE pivotal study aimed at developing a fully closed-loop automated insulin delivery system specifically for individuals with Type 2 Diabetes. The initiative marks a significant step forward in diabetes management and treatment technology.

ACTON, Mass.–(BUSINESS WIRE)–Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes